Consolidated Balance Sheets - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
| Current assets: |
|
|
| Cash and cash equivalents |
$ 101,136
|
$ 92,795
|
| Marketable securities |
53,153
|
92,975
|
| Collaboration receivable |
300,000
|
0
|
| Prepaid expenses and other current assets |
5,273
|
4,917
|
| Total current assets |
459,562
|
190,687
|
| Property and equipment, net |
17,563
|
19,528
|
| Restricted cash |
1,733
|
1,733
|
| Other assets |
2,400
|
842
|
| Operating lease right-of-use assets |
38,516
|
42,804
|
| Total assets |
519,774
|
255,594
|
| Current liabilities: |
|
|
| Accounts payable |
3,819
|
3,680
|
| Accrued expenses and other current liabilities |
9,562
|
9,161
|
| Operating lease liabilities |
6,994
|
3,981
|
| Deferred revenue |
28,317
|
2,024
|
| Total current liabilities |
48,692
|
18,846
|
| Notes payable, net of discount |
0
|
19,654
|
| Operating lease liabilities, net of current portion |
51,338
|
58,361
|
| Deferred revenue, net of current portion |
322,730
|
12,546
|
| Other liabilities |
143
|
0
|
| Total liabilities |
422,903
|
109,407
|
| Commitments and contingencies (Note 13) |
|
|
| Stockholders’ equity: |
|
|
| Preferred stock, $0.0001 par value; 25,000,000 shares authorized as of December 31, 2021 and 2020; no shares issued or outstanding |
0
|
0
|
| Common stock, $0.0001 par value; 175,000,000 shares authorized at December 31, 2021 and 2020; 41,299,720 shares issued and outstanding at December 31, 2021 and 36,790,946 shares issued and outstanding at December 31, 2020 |
4
|
4
|
| Additional paid-in capital |
361,133
|
309,126
|
| Accumulated other comprehensive loss |
(10)
|
(7)
|
| Accumulated deficit |
(264,256)
|
(162,936)
|
| Total stockholders’ equity |
96,871
|
146,187
|
| Total liabilities and stockholders’ equity |
$ 519,774
|
$ 255,594
|